Corvus Pharmaceuticals (CRVS)
(Delayed Data from NSDQ)
$2.05 USD
+0.07 (3.54%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $2.05 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/13/24 |
---|---|
Current Quarter | -0.12 |
EPS Last Quarter | -0.12 |
Last EPS Surprise | 0.00% |
ABR | 1.40 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.49 |
Next Year | -0.58 |
EPS (TTM) | -0.52 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.12 | -0.15 | -0.49 | -0.58 |
# of Estimates | 1 | 1 | 4 | 3 |
Most Recent Consensus | NA | NA | -0.50 | NA |
High Estimate | -0.12 | -0.15 | -0.39 | -0.38 |
Low Estimate | -0.12 | -0.15 | -0.55 | -0.75 |
Year ago EPS | -0.14 | -0.12 | -0.56 | -0.49 |
Year over Year Growth Est. | 14.29% | -25.00% | 12.50% | -17.69% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.12 | -0.15 | -0.49 | -0.58 |
7 Days Ago | -0.12 | -0.15 | -0.49 | -0.58 |
30 Days Ago | -0.12 | -0.15 | -0.49 | -0.58 |
60 Days Ago | -0.12 | -0.15 | -0.49 | -0.58 |
90 Days Ago | -0.12 | -0.15 | -0.47 | -0.69 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.12 | -0.15 | -0.49 | -0.58 |
Zacks Consensus Estimate | -0.12 | -0.15 | -0.49 | -0.58 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.12 | -0.14 | -0.12 | -0.14 | NA |
Estimate | -0.12 | -0.14 | -0.16 | -0.14 | NA |
Difference | 0.00 | 0.00 | 0.04 | 0.00 | 0.01 |
Surprise | 0.00% | 0.00% | 25.00% | 0.00% | 6.25% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more